A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research (Q45860645)
Jump to navigation
Jump to search
scientific article published in June 1991
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research |
scientific article published in June 1991 |
Statements
1 reference
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research (English)
1 reference
Birx DL
1 reference
Redfield RR
1 reference
Fowler A
1 reference
Ketter N
1 reference
Tramont E
1 reference
Polonis V
1 reference
Davis C
1 reference
Brundage JF
1 reference
Smith G
1 reference
Johnson S
1 reference
1 June 1991
1 reference
324
1 reference
24
1 reference
1677-1684
1 reference